## APPN: Appian Corporation - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.12 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: declining volume (59% of avg), momentum weakening (-10.8% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($37.45)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Appian (APPN): Assessing Valuation After Healthcare AI Recognition and HL7 AI Challenge Win**
- Source: Sahm | 20251201T052234 | Somewhat-Bullish | Relevance: 98%
-  Appian (APPN) recently gained recognition for its "Bring AI to Work(flow)" solution in healthcare, winning the HL7 AI Challenge and driving a 35.5% share price surge over the last month. While a popular narrative suggests the stock is 2.9% undervalued with a fair value of $41.60, a Discounted Cash Flow (DCF) model indicates it may be trading above fair value, challenging the market's optimism. Investors are navigating the potential upside from AI innovation against inherent market volatility and competitive threats.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-11 | Morgan Stanley | $45 | $29 | +55% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-11 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 9 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.9% (+13.0%)
- Blackrock Inc.: 8.0% (+6.7%)
- Lead Edge Capital Ma: 4.2% (+11.5%)
- Abdiel Capital Advis: 3.1% (-82.8%)
- Arrowstreet Capital,: 3.0% (+86.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-10.8% 5d) with bearish MACD, trend may be turning.
2. Elevated short interest (8.1%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.12 indicates undervaluation relative to growth. Analyst sentiment positive (1 raises, avg +55%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $3.0B |
| Beta | 0.85 |
| 52W Range | $24.00 - $46.06 |
| Short Interest | 8.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.12 |
| Forward P/E | 53.2 |
| Current P/E | 75.5 |
| YoY Growth | 42.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 10.4% to -0.4% (-10.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.4pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 59. Volume at 59% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.44% (CS: 55) | Neutral |
| RSI_14 | 59.2 | Neutral |
| MACD Histogram | -0.47 | Bearish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 1.197x | Above |
| vs SMA200 | 1.310x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $40.93
- **Stop Loss:** $37.45 (8.5% risk)
- **Target:** $47.89 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 344
- **Position Value:** $14,079.92
- **Portfolio %:** 14.08%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-18 (Est: $0.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.32 | +490.0% |
| 2025Q2 | $-0.13 | $0.00 | +103.0% |
| 2025Q1 | $0.03 | $0.13 | +315.7% |
| 2024Q4 | $-0.01 | $0.00 | +100.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*